SharonAnnSpencerMD

Radiation Oncology • Birmingham, AL

Associate Professor of Radiation Oncology, University Alabama

Join to view full profile

Are you Dr. Spencer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 87 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1717 6th Ave S
Birmingham, AL 35233
Phone+1 800-822-8816

Summary

Dr. Sharon Spencer, MD is a radiation oncologist in Birmingham, Alabama. She is currently licensed to practice medicine in Alabama. She is affiliated with Children's of Alabama, Cooper Green Hospital, and Birmingham VA Medical Center.

Education & Training

University of Alabama Medical CenterResidency, Radiation Oncology, 1983 - 1988
University of Alabama School of MedicineClass of 1983

Certifications & Licensure

AL State Medical License 1984 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
America's Top Doctors for Cancer Castle Connolly, 2005

Clinical Trials

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor Start of enrollment: 2002 Jul 01
Completed
Phase 3
Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer Start of enrollment: 2002 Sep 01
Completed
Phase 1, Phase 2
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer Start of enrollment: 2010 Oct 28
Completed
Phase 2
Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) Start of enrollment: 2010 Oct 01
Completed
Phase 1
Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy Start of enrollment: 2011 Jul 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

742 citations
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari
Lancet. 2019-01-05
1345 citations
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-indu...
James A. Bonner, Paul M. Harari, Jordi Giralt, Roger B. Cohen, Christopher U. Jones
The Lancet. Oncology. 2010-01-01
41 citations
Glioma-Associated Oncogene Family Zinc Finger 1 Expression and Metastasis in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiation Therapy (RTOG 9...
Christine H. Chung, James J. Dignam, M. Elizabeth H. Hammond, Alexander C. Klimowicz, Stephanie K. Petrillo
Journal of Clinical Oncology. 2011-04-01

Press Mentions

CT, MRI Determined Her Tumor Was Benign—but Surgery Revealed OtherwiseJune 20th, 2018
Scientist Who Grew from Fairfield Plants Seeds, Aspires to Nurture Others Beyond STEMMay 31st, 2017